Alli Pioneers EU Centralized Process For Nonprescription Switch

 
• By Katie Stevenson

The European Medicines Agency's clearance of GlaxoSmithKline's weight-loss drug alli for nonprescription status across the European Union marks the first success for a centralized Rx-to-OTC switch process

More from Archive

More from Pink Sheet